Navigation Links
Sinovac Reports Unaudited Second Quarter 2011 Financial Results
Date:8/12/2011

We anticipate that the Certificate of Approval for Anflu will be granted in the coming months as we prepare for the commercial launch of the vaccine in Mexico."

Dr. Yin concluded, "We are encouraged by the second quarter sales activity and public market orders received in recent months.  We believe that the ongoing execution of our revised sales strategy and seasonal flu vaccine sales that typically take place in the second half of the year will enable continued revenue growth. We look forward to updating you on the continued progress across our vaccine development pipeline."

Financial Review for the Second Quarter Ended June 30, 2011 Sales for the second quarter 2011 were $15.7 million, up 52.5% from $10.3 million for the second quarter of 2010. During the second quarter 2011, Sinovac recorded $7.7 million in pandemic influenza vaccine sales on prior year order.

Sinovac's sales breakdown by product was as follows.Three months ended June 30,2011

2010SalesHepatitis vaccines

$8,097,941

$8,676,883Influenza vaccines

7,558,158

1,586,823Total

$ 15,656,099

$ 10,263,706Gross profit for the second quarter 2011 was $10.8 million, with a gross margin of 68.8%, compared to $8.5 million and a gross margin of 82.7% for the same period of 2010.  After deducting depreciation of land use rights and amortization of licenses and permits, the gross margin was 67.9% and 81.7% for the second quarter of 2011 and 2010, respectively. The gross profit margin was adversely affected by the revenue recognition in the second quarter 2011 of the prior pandemic flu vaccine order that had a lower gross margin than other vaccine products.

Selling, general and administrative expenses for the second quarter 2011 were $5.0 million, compared to $4.0 million in the same period of 2010. SG&A expenses as a percentage of second quarter 2011 sales were 31.8%, compared to 38.9% during the second quarter of the pr
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Sinovac Announces Management Changes
2. Sinovac Holds 2011 Annual Shareholders Meeting
3. Sinovac Appoints Kenneth Lee to Board of Directors
4. Sinovac Reports Positive Phase I Clinical Trial Results for EV71 Vaccine Candidate Against Hand, Foot & Mouth Disease(HFMD)
5. Sinovac Reports Unaudited First Quarter 2011 Financial Results
6. Sinovac Presents at Two Investor Conferences in May 2011
7. Sinovac Files Annual Report on Form 20-F
8. Sinovac Participates in UBS Greater China Healthcare Corporate Day
9. Sinovac Reports Positive Preliminary Phase I Clinical Trial Results for EV71 Vaccine in Adult Group
10. Sinovac Biotech Submits Clinical Trial Application to SFDA for Pneumococcal Conjugate Vaccine (PCV)
11. Sinovac Provides Preliminary Unaudited Fourth Quarter 2010 Sales Range
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... , July 11, 2014 According ... Research "Endoscopy Devices Market (Endoscopes, Endoscopic Operative Devices, and ... Trends and Forecast, 2013-2019" the global endoscopy devices market ... is expected to grow at a CAGR of 6.8% ... of USD 36.9 billion in 2019. Browse ...
(Date:7/11/2014)... , July 11, 2014  Veran Medical ... announced today the positive, cost-effective final results ... SPiNPerc™ procedure. The SPiNPerc endobronchial percutaneous biopsy ... percutaneous approach to biopsy when a traditional ... and physicians experience positive financial outcomes when ...
(Date:7/11/2014)... , July 11, 2014 Neurelis, Inc. ... ("Biotie") to end the option held by Biotie to ... further development of NRL-1 (intranasal diazepam) for pediatric and ... Over the past year, Biotie has advanced the ... preparation for the pivotal clinical work required for NDA ...
Breaking Medicine Technology:Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6Veran Medical Publishes Lung Cancer Patient Management Study 2Neurelis Regains Rights to Intranasal Diazepam Program 2Neurelis Regains Rights to Intranasal Diazepam Program 3
... ALEXANDRIA, Va., Sept. 1 The ... of a new website, www.PharmacyMatching.com to ... their pharmacy, existing owners who desire additional stores ... become a pharmacy owner. (Logo: ...
... Sept. 1 Eli Lilly and Company (NYSE: ... for the Federal Circuit has affirmed a prior ruling by ... that the company,s method-of-use patents for Evista® (raloxifene HCl tablets) ... U.S. through March of 2014. "We are pleased ...
Cached Medicine Technology:NCPA Launches www.PharmacyMatching.com to Connect Independent Pharmacy Buyers and Sellers 2NCPA Launches www.PharmacyMatching.com to Connect Independent Pharmacy Buyers and Sellers 3U.S. Court of Appeals Upholds Validity of Lilly's Evista Patents Through March of 2014 2
(Date:7/14/2014)... The Encino cosmetic dentist at ... and porcelain veneers. These restorations are an excellent ... and greater loss of healthy tooth tissue. They work ... flaws on the tooth. Encino dentist Dr. Mastour and ... ensure they offer the most appropriate treatment recommendations for ...
(Date:7/14/2014)... HealthDay Reporter SUNDAY, July ... a faltering sense of smell might signal the early ... smell test could spot who needs more extensive screening ... ability to identify odors was associated with the loss ... "We,re trying to be able to diagnose Alzheimer,s ...
(Date:7/14/2014)... HealthDay Reporter MONDAY, July ... linked to multiple health issues, but dementia isn,t one of ... widowhood may even delay dementia, the researchers found. "For ... was associated with a later age of developing full-blown dementia ... Bryan Woodruff. Woodruff, an assistant professor of neurology ...
(Date:7/14/2014)... Connecticut (PRWEB) July 14, 2014 ... is celebrating its Grand Opening on Monday, July ... Connecticut 06830. The celebration will last all week ... all new patients. Everyone is welcomed to attend. ... M.D. who provides physician-administered skincare, anti-aging, weight loss ...
(Date:7/14/2014)... Huntington Beach, CA (PRWEB) July 14, 2014 ... of thousands of people undergo plastic surgery to reduce ... hit the market, however, eliminates the need to go ... mouth guard that works the jaw muscles, therefore tightening ... of having two chins. , Jawflex is used for ...
Breaking Medicine News(10 mins):Health News:Encino Esthetic Dental Group is Now Offering Lumineers and Porcelain Veneers 2Health News:Could a Simple Smell Test Help Spot Alzheimer's Early? 2Health News:Could a Simple Smell Test Help Spot Alzheimer's Early? 3Health News:Widowhood May Delay Dementia in Some Seniors, Study Finds 2Health News:Widowhood May Delay Dementia in Some Seniors, Study Finds 3Health News:The Cosmetic Medic Announces Grand Opening of New Skin M.D., a Physician-Administered Anti-aging, Skincare, and Weight Loss Practice 2Health News:The Cosmetic Medic Announces Grand Opening of New Skin M.D., a Physician-Administered Anti-aging, Skincare, and Weight Loss Practice 3Health News:Jawflex | Double Chin Exercise for Double Chin Reduction 2
... based on computerized simulation models suggests that the lifetime risk ... tomography (CT scan) coronary angiography varies widely, with the risk ... disease (CAD) is the leading cause of death in men ... 5 deaths, and a major cause of health care expenditures, ...
... reveals abnormal cells the woman will be offered colposcopy, ... cervix with a special microscope. Many women find the ... of anxiety before and during colposcopy. ,,Researchers ... trials that involved a total of 1441 women and ...
... The U.S. Food and Drug Administration (FDA) has approved the ... degenerative disc disease , one of the most common causes ... approved, the Prestige Cervical Disc, is manufactured by Medtronic Sofamor ... disc means that people with cervical degenerative disc disease now ...
... law to curb smoking to secure peoples' rights to the ... much committed towards implementing a comprehensive anti-tobacco law to reduce ... children and adolescents," Ali bin Shukur, Under-secretary of the Ministry ... ,A draft bill on smoking is being deliberated at ...
... of researchers have found that combining pre-operative chemotherapy and ... six percent when compared with surgery alone. ... the MRC Clinical Trials Unit in London after they ... from seven of these trials were available from trial ...
... a plan for coping with a pandemic flu outbreak, the ... disease outbreak and track its progress across the country. ... the borders if a pandemic flu outbreak occurs somewhere in ... president for biodefense:The reality is that there are tremendous challenges ...
Cached Medicine News:Health News:CT Scan Radiations may Lead to Cancer 2Health News:FDA Approves First Artificial Cervical Disc 2Health News:Chemotherapy Better for Non Small Cell Lung cancer 2Health News:Americas Preparations For Flu Outbreak Still Incomplete 2
RIA kit for the quantitative determination of autoantibodies to thyroid peroxidase (TPO) in serum....
For the quantitative determination of Estradiol (E2) concentration in human serum or plasma....
... quantitative determination of Estradiol (E2) concentration in human ... steroid hormone with a phenolic A ring. ... 272.4. It is the most potent natural ... in smaller amounts by the adrenal cortex, and ...
... Cardiac troponin I (cTnI) has been ... presenting to Emergency Departments (ED) with chest ... is diagnosed when blood levels of sensitive ... the MB isoenzyme of creatine kinase (CK-MB), ...
Medicine Products: